DeepSeek-R1 charts a new path for AI through explaining its own reasoning process. Why does this matter and how will it benefit the world?

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

Ainnocence has achieved significant milestones in applying artificial intelligence to accelerate antibody discovery for ...

Researchers from Zhejiang University and HKUST (Guangzhou) have developed a cutting-edge AI model, ProtET, that leverages ...

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...